Alvotech (ALVOW)
1.56
-0.31 (-16.58%)
At close: Mar 28, 2025, 3:39 PM
1.56
0.00%
After-hours: Mar 28, 2025, 04:00 PM EDT
Company Description
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets.
The company is based in Iceland.
Alvotech

Country | IS |
IPO Date | Jun 16, 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 999 |
CEO | Robert Wessman |
Contact Details
Address: Saemundargata 15-19 Reykjavik, IS | |
Website | https://www.alvotech.com |
Stock Details
Ticker Symbol | ALVOW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001898416 |
CUSIP Number | L01800116 |
ISIN Number | LU2458333858 |
Employer ID | 98-1629342 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Robert Wessman | Chief Executive Officer, Founder & Executive Chairman |
Faysal Kalmoua | Chief Operating Officer & Director |
Joel Morales | Chief Financial Officer |
Anil Okay | Chief Commercial Officer |
Benedikt Stefansson | Vice President of Investor Relations and Global Communications |
Giedrius Zunda | Chief Technical Officer |
Jenny Sif Steingrimsdottir | Vice President of People & Culture |
Joseph E. McClellan | Chief Scientific Officer |
Ming Li | Chief Strategy Officer |
Tanya Zharov | General Counsel |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2025 | 6-K | Filing |
Mar 27, 2025 | 20-F | Filing |
Mar 27, 2025 | 6-K | Filing |
Mar 26, 2025 | 6-K | Filing |
Mar 20, 2025 | 6-K | Filing |
Mar 18, 2025 | 6-K | Filing |
Feb 24, 2025 | 6-K | Filing |
Feb 18, 2025 | 6-K | Filing |
Jan 27, 2025 | 6-K | Filing |
Dec 23, 2024 | 6-K | Filing |